ARCHIVES

Cancer Groups Endorse Richard Pazdur for Head of FDA’s New Office of Oncology Drug Products. Five Candidates Are In the Running for the Job, Sources Said.

This article is from The Cancer Letter archive.

Vol. 31 No. 07 | February 18, 2005

Download PDF Visit The Full Archive

Related Articles

GAO Report Finds Increase in Self-Referred Pathology Services

August 9, 2013

Lippman Named UCSD Cancer Center Director

May 4, 2012

Neratinib Graduates from I-SPY Phase II Adaptive Trial Regimen

April 25, 2014

825,000 Pounds of Yew Bark Clleced in ’91 For 10,000 Patients

March 13, 1992

ACS Report Says Drop in Cancer Mortality Saved 898,000 Lives Over 17 Years

June 17, 2011

EORTC Places Same Number on Phase 2-3 Trials As In U.S.

December 12, 1986